| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003380319 |
| P356 | DOI | 10.1186/1745-6215-8-9 |
| P932 | PMC publication ID | 1821040 |
| P698 | PubMed publication ID | 17341316 |
| P5875 | ResearchGate publication ID | 6466094 |
| P50 | author | Paula Williamson | Q21264497 |
| Ley Sander | Q6537960 | ||
| Carrol Gamble | Q64496254 | ||
| P2860 | cites work | Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures | Q24248718 |
| Carbamazepine versus phenobarbitone monotherapy for epilepsy | Q24250193 | ||
| Comparison of two methods to detect publication bias in meta-analysis | Q29617904 | ||
| Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
| Carbamazepine versus valproate monotherapy for epilepsy | Q30887426 | ||
| Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials | Q31170846 | ||
| Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...] | Q33202375 | ||
| Identification and impact of outcome selection bias in meta-analysis | Q33209578 | ||
| A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group | Q33732579 | ||
| Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial | Q33733543 | ||
| Modelling publication bias in meta-analysis: a review | Q34146621 | ||
| Publication bias and clinical trials | Q34179248 | ||
| Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures | Q34195429 | ||
| Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures | Q34424616 | ||
| Which drug for the adult epileptic patient: phenytoin or valproate? | Q34491586 | ||
| The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial | Q34611908 | ||
| Outcome selection bias in meta-analysis | Q36296533 | ||
| Better comparisons of antiepileptic drugs: what measures of efficacy? | Q41642470 | ||
| Evaluation of drug treatment outcome in epilepsy: a clinical perspective | Q41642476 | ||
| A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group | Q45336272 | ||
| In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias | Q51967379 | ||
| Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy | Q52170138 | ||
| Investigation of within-study selective reporting in clinical research: follow-up of applications submitted to a local research ethics committee | Q52941855 | ||
| A bound for publication bias based on the fraction of unpublished studies | Q79801825 | ||
| P921 | main subject | bias | Q742736 |
| P304 | page(s) | 9 | |
| P577 | publication date | 2007-03-06 | |
| P1433 | published in | Trials | Q7840023 |
| P1476 | title | Application and investigation of a bound for outcome reporting bias | |
| P478 | volume | 8 |
| Q38161501 | A model-based correction for outcome reporting bias in meta-analysis |
| Q33925976 | Assessing the potential for outcome reporting bias in a review: a tutorial |
| Q43795882 | Bias in systematic reviews? |
| Q41318701 | Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol |
| Q33901424 | Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol) |
| Q47307407 | Model-based sensitivity analysis for outcome reporting bias in the meta analysis of benefit and harm outcomes |
| Q28752005 | Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications |
| Q24236379 | Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients |
| Q28598096 | Outcome Reporting Bias in Government-Sponsored Policy Evaluations: A Qualitative Content Analysis of 13 Studies |
| Q28066876 | Psychological interventions to improve psychological well-being in people with dementia or mild cognitive impairment: systematic review and meta-analysis protocol |
| Q36689367 | Psychological treatments for common mental health problems experienced by informal carers of adults with chronic physical health conditions (Protocol). |
| Q38089321 | Reporting completeness of abstracts of systematic reviews published in leading dental specialty journals. |
| Q37080259 | Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study. |
| Q34781810 | Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis |
| Q29619094 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias |
| Q26851424 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review |
Search more.